Cyclacel Pharma (CYCC) Misses Q3 EPS by 18c
Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.18). Revenue for the quarter came in at $10 thousand.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.18). Revenue for the quarter came in at $10 thousand.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.